Anthracycline Antibiotics in Cancer Therapy
- 1 February 1994
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 47 (2), 223-258
- https://doi.org/10.2165/00003495-199447020-00002
Abstract
30 years ago an anthracycline antibiotic was shown to have antineoplastic activity. This led to the development of well over 1000 analogues with a vast spectrum of biochemical characteristics. Many...Keywords
This publication has 99 references indexed in Scilit:
- Idarubicin cardiotoxicity in acute myeloid leukaemiaThe Lancet, 1992
- Neurological symptoms and coma associated with doxorubicin administration during chronic cyclosporin therapyThe Lancet, 1992
- Doxorubicin: monoclonal antibody conjugate for therapy of human cervical carcinomaInternational Journal of Cancer, 1992
- Atrial natriuretic peptide as a marker for doxorubicin-induced cardiotoxic effectsCancer, 1992
- Two independent amsacrine-resistant human myeloid leukemia cell lines share an identical point mutation in the 170 kDa form of human topoisomerase IIJournal of Molecular Biology, 1992
- Reversal of Drug Resistance in a Human Colon Cancer Xenograft Expressing MDR1 Complementary DNA by In Vivo Administration of MRK-16 Monoclonal AntibodyJNCI Journal of the National Cancer Institute, 1991
- In vitro evaluation of the association of thermosensitive liposome-encapsulated doxorubicin with hyperthermiaEuropean Journal of Cancer and Clinical Oncology, 1991
- Liver targeting of autologous erythrocytes loaded with doxorubicinEuropean Journal of Cancer and Clinical Oncology, 1991
- Cross-resistance of an amsacrine-resistant human leukemia line to topoisomerase II reactive DNA intercalating agents. Evidence for two topoisomerase II directed drug actionsBiochemistry, 1991
- Serial Assessment of Doxorubicin Cardiotoxicity with Quantitative Radionuclide AngiocardiographyNew England Journal of Medicine, 1979